Aemetis (AMTX) Q3 2026 Earnings Call Transcript

Aemetis reported Q3 2026 revenue up 49% year over year to $88.2 million, net income of $5.2 million versus a $23.7 million loss a year earlier, and adjusted EBITDA of $24.8 million versus negative $5 million. Results included $24.7 million of Section 45Z credits, including an $11 million cumulative true-up; RNG sales volume rose 39% to 158,200 MMBtu. Management expects its mechanical vapor recompression project to add about $32 million in annual cash flow, with financial benefits weighted toward the second half of 2027, while flagging potential rail disruptions and delays from electric-component supply constraints.

Analysis

The earnings inflection is real but its durability is not yet established: a material portion of reported 45Z revenue reflects a regulatory-model repricing and a prior-quarter true-up, while cash conversion remains the key test. The reported $3.4m quarter-end cash balance alongside substantial investment and a looming preferred-unit redemption date makes liquidity, financing terms, and credit-sale timing more important than the headline profit. Treat management’s projected $32m annual MVR cash contribution as an execution case, not a base case; equipment delays, commissioning, and the lag between credit accrual and cash realization could push benefits out or require additional funding.

For the next 1–3 months, the catalysts are MVR schedule updates, further CARB pathway approvals, monetization of 45Z credits, and India export approvals. Seasonal RNG output and possible rail disruption add near-term volatility. Over 6–18 months, successful MVR commissioning and incremental RNG capacity could improve unit economics, but policy/model revisions or weaker LCFS/RIN values would reduce the credit stack. California E15 could support ethanol demand and local capacity utilization, though competitors and imported supply may capture part of that upside. Higher corn-oil output may benefit renewable diesel and SAF producers by adding a low-CI feedstock, while increasing competition among feedstocks.

Contrarian read: the quarter may encourage investors to capitalize a policy-driven peak run rate before recurring cash generation is demonstrated. Conversely, the market may underappreciate the operating leverage if MVR and credit pathways deliver on schedule. Verify cash flow, debt/preferred obligations, credit-sale discounts, and project funding in filings before assigning either outcome.

Key Decisions for Investors

• Do not chase AMTX on the reported quarter alone. Keep it on a catalyst watchlist pending evidence that operating cash flow and cash balances improve after credit monetization and capital spending.
• For an event-driven long, wait for documented MVR commissioning progress and a financing/liquidity update; size cautiously. Falsify the thesis if commissioning slips materially beyond management’s first-half-2027 window, funding needs rise, or recurring credit-adjusted cash generation disappoints.
• Monitor 45Z and LCFS realization separately from accruals: track realized sale discounts, receivables, and any regulatory or model changes. A weaker credit price or slower cash collection would undermine the earnings inflection even if production grows.
• Watch rail service, corn costs, and California ethanol availability as near-term spread indicators. A disruption could tighten regional supply and support realized ethanol pricing, but could also constrain AMTX’s feedstock deliveries; avoid treating this as an unambiguously positive catalyst.